Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'fMet-Leu-Phe receptor' and Ligand = 'BDBM497400'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM497400 (US11008301, Example 34) Show SMILES CS(=O)(=O)N1CCN(CC1)c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O |r| Show InChI InChI=1S/C24H28F3N5O4S/c1-37(35,36)31-15-13-30(14-16-31)19-8-10-20(11-9-19)32-12-2-3-21(22(32)33)29-23(34)28-18-6-4-17(5-7-18)24(25,26)27/h4-11,21H,2-3,12-16H2,1H3,(H2,28,29,34)/t21-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	2.20E+3	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US11008301 (2021) BindingDB Entry DOI: 10.7270/Q2HX1GTH
					More data for this Ligand-Target Pair